Skip to contentI
Integra Lifesciences Holdings Corp
I
IARTIntegra Lifesciences Holdings Corp Q3 2016 · 10-Q
Revenue$250.33M$250.33M+10.6% vs Q3 2015 Net Income$20.14M$20.14MN/M vs Q3 2015 EPS Diluted$0.25$0.25N/M vs Q3 2015 Gross Profit$161,003,000+14.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR
Operating Cash Flowderived$46,767,000+138.5% Free Cash Flowderived$39,793,000+179.2% Margins · derivedGross margin64.3%+2.3 pt vs Q3 2015
Operating margin12.0%+7.6 pt vs Q3 2015
Net margin8.0%+22.1 pt vs Q3 2015
ended Sep 30, 2016 · filed Oct 28, 2016 · 28 d after period end